Olympus recently announced the FDA approval of the Endo Capsule for the visualization of the small bowel mucosa, part of Olympus’ EnteroPro brand, a total solution designed to help physicians diagnose and treat small bowel abnormalities.
Endo Capsule includes features that reportedly provide physicians with unprecedented imaging capabilities of the small bowel, including high resolution, a wider field of view and an enhanced depth of field, automatic brightness control, advanced color reproduction and structure enhancement. A portable, lightweight real-time viewer allows physicians to verify its full functionality before the patient ingests the capsule, and Endo Capsule can easily be activated or deactivated, if needed, to conserve battery power prior to ingestion, according to its manufacturer. Patients carry its data recorder in a lightweight harness, allowing them to conduct daily activities while the capsule is recording images.
May 19, 2026 
